Research on opioids, addiction, and treatment. Covers traditional care practices, opioid treatment in pregnancy, illicit fentanyl, and treatment disparities.
Prescription volumes for stimulant and antidepressant medications rose, while opioid volumes decreased between 2019 and 2022. Telehealth prescriptions climbed across medications, with a notable increase in opioids.
A new study found that oxycodone consumption in Australia decreased by 45% from 2019 to 2020, coinciding with national policy changes. The Australian National Prescribing Service launched initiatives to improve opioid prescribing practices, including training and reduced package sizes.
A study of 164,170 Medicare beneficiaries reveals racial disparities in opioid prescriptions after hip fracture hospitalization. Black and Asian patients receive significantly lower doses of opioids compared to white patients.
Researchers investigate synthetic oxytocin as a potential pain reducer and addiction curber for susceptible older adults. A two-year study with NIH funding aims to evaluate the effects of oxytocin on acute pain management and opioid use.
Evan Lowder and Chelsea Foudray are conducting a study to assess MOUD provision in the Fairfax County Adult Detention Center, with funding from Fairfax County and the Virginia Opioid Abatement Authority. The study aims to inform best practices for initiating individuals into medication-assisted treatment upon release from jail.
A study found that only six states successfully delivered medications for opioid use disorder to at least 50% of people referred to treatment by the criminal legal system. This disparity leads to a high risk of overdose death among individuals leaving jails and prisons, highlighting the need for better access to effective treatments.
A study by Brown University researchers found that fentanyl's introduction into Oregon's unregulated market contributed to the state's overdose rate increase. Decriminalization of drug possession was not linked to an rise in fatal overdoses.
A recent study found that Quebec's drug-related mortality rates increased over time, peaking in 2020, due to the contamination of the drug market. Fentanyl and new synthetic opioids are on track to become the most commonly detected substances in opioid poisoning deaths.
A study at Karolinska Institutet reveals that morphine activates a 'morphine ensemble' of neurons in the brain, leading to pain relief. This understanding may help develop new strategies to treat pain without triggering addiction and overdose.
Researchers at the University of Calgary are conducting a clinical trial using probenecid, an anti-gout medication, to treat debilitating opioid withdrawal symptoms. The study's lead authors aim to develop a potential treatment for the disabling symptoms of opioid withdrawal, which can be crippling.
A new study found that communities with pharmacies implementing a state standing order to distribute naloxone without a prescription showed a significant decrease in opioid-related deaths. The analysis, conducted from 2013 to 2018, observed a gradual decline of 16% per year in cities with naloxone distribution, compared to those without.
A new study found that communities with pharmacies dispensing standing order naloxone experienced a gradual and significant decrease in opioid deaths, averaging 16% per year. This suggests that expanding access to naloxone through state-mandated standing orders can save lives and reduce opioid fatality rates.
Researchers found that women with opioid use disorder face structural barriers and stigma that may keep them from engaging with traditional harm reduction practices. Increasing accessibility of harm reduction tools and expanding education are key recommendations to reduce overdose risk for women.
A recent study found that 20% of patients with chronic cough received an opioid prescription, with older patients and those with Medicaid insurance more likely to be prescribed these drugs. The research team hopes to explore alternative treatment options to reduce reliance on opioids for chronic cough care.
A recent UC Davis Health study found that administering naloxone to patients with opioid-associated out-of-hospital cardiac arrest (OHCA) significantly improves return of spontaneous circulation and survival rates. The study analyzed data from San Francisco, Sacramento, and Yolo county EMS agencies between 2015-2023.
Brigham researchers created an implantable device that continuously monitors vital signs and delivers naloxone when detecting opioid overdose. The 'iSOS' device has shown effectiveness in preclinical models, offering a potential solution to the devastating effects of the opioid epidemic.
Researchers have developed an implantable device that can independently detect opioid overdose and automatically administer naloxone, with promising results in animal trials. The device, called iSOS, uses multiple sensors to continuously monitor vital signs and rapidly release naloxone when needed.
Researchers at MIT and Brigham and Women's Hospital have developed an implantable device that monitors vital signs and releases naloxone to reverse opioid overdoses. The device has shown success in reversing overdoses in animals, with a 96% recovery rate.
A new study found that pharmacies in racially and economically segregated communities are more likely to restrict buprenorphine dispensing, hindering access to treatment for opioid use disorder. This can lead to a threefold increase in overdose fatality rates among Black and Hispanic/Latinx communities.
Researchers discovered that opioid receptors in the dorsal peduncular nucleus respond uniquely to opioids, blocking aversive feelings and leading to reward. This finding contributes to the pleasurable and addictive qualities of opioids.
Pregnant women exposed to buprenorphine combined with naloxone had similar or more favorable outcomes compared to those exposed to buprenorphine alone. This suggests that both formulations are safe treatment options for opioid use disorder during pregnancy.
A new study led by UMass Amherst and Tufts Medical Center will provide HIV prevention, diagnosis, and treatment for people with opioid use disorders who are incarcerated. The study aims to increase the number of incarcerated individuals tested and treated, addressing a critical gap in healthcare access.
A review of 148 studies found nearly one in ten patients experience opioid dependence or disorder, while nearly one in three show symptoms. The study emphasizes the need for accurate estimates to develop effective interventions and manage the problem.
Researchers found that witnessing community members engage in prosocial behaviors increases policymakers' willingness to support pro-social policies, such as syringe service programs. The study suggests that communities can exert a positive influence on authorities and contribute to the greater good.
A new study found that patients in hospitals with specialized addiction consult services were more likely to start and continue lifesaving medication for opioid use disorder treatment after discharge. The CATCH program, a hospital-based intervention, showed promising results in increasing treatment initiation and retention rates compar...
Researchers at Boston Medical Center found that medications for opioid use disorder were underused in Massachusetts despite improving outcomes. The study highlighted disparities among patients who received treatment, including younger people and Black patients being less likely to receive medication.
A nationwide study found a marked increase in new GLP-1RA prescriptions for obesity, particularly since 2020. Semaglutide was the most prescribed GLP-1RA, but prescriptions among those with obesity without type 2 diabetes spiked, worsening existing racial and ethnic disparities.
Researchers have identified a strategy to design safer opioids that suppress pain with fewer side effects. An experimental opioid, RO76, was found to produce a signal within cells that differs from those initiated by classic opioids, leading to reduced breathing rates and withdrawal symptoms.
Researchers at Mainz University have identified aniquinazolin B, a natural substance from the marine fungus Aspergillus nidulans, which stimulates opioid receptors and could potentially replace opioids in the long term. The compound shows promising results with fewer undesirable reactions compared to opioids.
Researchers identified a viable path to developing a novel therapy that would make opioids more effective and safer as a treatment for chronic pain. The study found that selective Hsp90 inhibitors amplified the pain-relieving effects of morphine, reducing tolerance and side effects.
A new technological breakthrough has enabled scientists to visualize opioid signaling in the brain in real-time, providing a deeper understanding of how opioids affect the brain. This breakthrough has opened up new avenues for developing more effective and safer therapeutics for pain management and mental health disorders.
A Canadian study found that prescribing lower quantities of opioids can help reduce misuse and overdose. The study suggests adapting prescription practices to patients' analgesic needs, with varying quantities based on the type of pain condition.
A study published by University at Buffalo researchers found that telemedicine referrals led to increased patient retention in treatment, with 65.1% of telemedicine patients still in care at the 30-day mark versus 22.2% of those referred from an emergency department visit. This suggests that telemedicine can remove barriers to care and...
A recent study published in JAMA Health Forum found that opioid-exposed newborns are 41% more likely to be discharged home with their biological mother when mothers receive medication for opioid use disorder during pregnancy. This reduction in risk is significant, as it can have a positive impact on families and the child welfare system.
Treatment approaches for opioid use disorder are underreported and inadequate in US substance use treatment facilities, with more than one-third lacking medications for OUD. The study highlights the need for improved treatment options to address the opioid epidemic.
A study found that 1 in 6 youths fill an opioid prescription prior to surgery and 3% continue using them three to six months later. Persistent opioid use among adolescents is a concern due to genetic, neurobiological, and social vulnerabilities.
A randomized controlled trial found that support from a peer recovery support specialist was as effective in reducing opioid overdose as support from a licensed clinical social worker. The trial included 648 ED patients at high risk of opioid overdose and showed no significant difference between the two groups in fatal opioid overdoses.
Researchers have identified a novel compound that can reverse the lethal effects of opioid overdose when paired with naloxone, reducing withdrawal symptoms and extending protection. The discovery builds on new insights into opioid receptors and could combat the devastating fentanyl epidemic.
A study published in JMIR Medical Informatics found that machine learning can accurately classify patients into differing levels of opioid use disorder (OUD) risk, demonstrating substantial agreement with clinicians' reviews. The research suggests that this technology can enhance personalized and safer care for patients early in opioid...
Researchers have identified a potential compound that enhances naloxone's effectiveness in reversing opioid overdoses by making it more potent and longer-lasting. The compound, dubbed compound 368, was found to improve naloxone's ability to counteract opioid overdoses in mice and enable reversal at lower doses.
Researchers discover a novel compound that can work alongside naloxone to reverse opioid overdoses, reducing withdrawal symptoms and enhancing naloxone's life-saving effects. The new compound, known as compound 368, binds next to naloxone on opioid receptors, holding it in place and slowing its natural degradation.
A recent study found that US medical boards are often lenient when disciplining doctors for misconduct related to opioid overprescription. Researchers examined 100 cases and found that only six cases resulted in a doctor's license being revoked, with most receiving lighter disciplines such as temporary suspension or probation.
Two studies published by researchers at the University of Michigan found that a handful of common surgical procedures, such as tonsillectomies and C-sections, account for large shares of all opioids dispensed after surgery. The studies suggest opportunities to reduce surgical opioid prescribing without compromising pain control.
Pharmaceutical companies exploited a loophole in the DEA's monitoring system, leading to an oversupply of opioids in communities. The study highlights the impact on Black communities, where overdose deaths tripled from 2014 to 2020. High supply chain complexity played a key role in evading regulations.
A study of 450 community outpatient mental health facilities found that approximately one-third offered medications for opioid use disorder. The availability of these medications highlights the need for further research on uptake and effective referral models.
A new study by Michigan Medicine University found that nearly all patients with buprenorphine prescriptions filled them, even when paying more out-of-pocket. The researchers suggest removing barriers to continuous prescribing as the main focus of efforts.
The NIH-funded HEALing Communities Study found that a data-driven intervention did not significantly reduce opioid-related overdose deaths, despite engaging communities in evidence-based practices. The study suggests that factors like the COVID-19 pandemic and increasing fentanyl presence may have weakened the impact of the intervention.
A study published in JAMA found that high out-of-pocket costs are a significant barrier to filling naloxone prescriptions. The study, which utilized data from a national pharmacy transactions database, estimated that a $10 increase in cost would decrease the rate of filling prescriptions by about 2-3 percentage points.
Researchers at UC San Diego School of Medicine are developing an AI model to predict opioid addiction in high-risk patients. The model uses generative artificial intelligence to analyze genomic, social determinants of health, clinical, procedural, and demographic data to identify patients at greatest risk.
Researchers found a coordinated effort by Mallinckrodt to reframe concerns about addiction as phobia and muddle dependence as pseudoaddiction. The company employed tactics like recruiting influencers, planting articles in scientific journals, and developing continuing medical education courses to boost sales.
A new study of 11,000 overdose deaths in Pennsylvania found that Black people who died from an overdose were half as likely to have received naloxone as white people. This racial disparity in naloxone administration highlights the need for targeted strategies to distribute life-saving medication and educate communities about its use.
A recent analysis reveals that Black individuals in Pennsylvania are less likely to receive naloxone, a medication that reverses opioid overdose. Hispanic decedents had similar odds of naloxone administration as white decedents.
Researchers found that five cannabis terpenes reduced chronic neuropathic pain levels comparable to morphine. The combination of terpenes and morphine enhanced pain relief without negative side effects. Terpenes offer an alternative to opioids for pain management with a better side effect profile.
A new study explores the growing fentanyl smoking culture in San Francisco, highlighting individual experiences and local trends. Participants reported fear of overdose and challenges with injecting as motivations for switching to smoking, but some expressed concerns about hygiene and residue risks.
Scientists at UNC-Chapel Hill discovered that xylazine binds too kappa opioid receptors, suggesting why fentanyl/xylazine withdrawal is so harsh. This finding could have big implications for future scheduling recommendations and treatment approaches for patients experiencing respiratory depression.
Law enforcement seizures of illicit fentanyl increased dramatically between 2017 and 2023, with 115 million pills seized in 2023 compared to 49,657 in 2017. The proportion of fentanyl pill seizures quadrupled, posing significant risks to public health.
Fentanyl seizures in the US increased by 1,700% between 2017 and 2023, with pills accounting for nearly half of total seizures. The West region saw a significant increase in fentanyl pill seizures, while the South had the highest number of powder form seizures.
Starting people with opioid use disorder on extended-release, injectable naltrexone within five to seven days of seeking treatment is more effective than the standard method. This rapid treatment protocol requires closer medical supervision and could make XR-naltrexone a more viable option for treating opioid use disorder.
A comprehensive analysis of seized counterfeit pills found that 99.3% contained fentanyl, with 67% also containing para-fluorofentanyl. The study highlights the importance of understanding the contents of counterfeit prescription pills for effective treatment approaches.
A telehealth program created by Project ECHO has been found to reduce reliance on opioids in pain management. The program connects primary care providers with experts via videoconferencing, leading to lower rates of opioid prescribing and greater adherence to evidence-based recommendations.